Tag: Health Claims

Displaying 1 - 20 of 667 results.

Pages

Filtering by content type: Press Release

Following a public comment period, the Federal Trade Commission has approved a final consent order settling deceptive advertising charges against Telomerase Activation Sciences, Inc. and Noel Patton (collectively, TA Sciences).
The Federal Trade Commission is mailing 2,116 refund checks totaling more than $355,000 to people who bought CogniPrin, a deceptively marketed ‘memory improvement’ supplement. The average check amount is $168.08, and represents full refunds.
The Federal Trade Commission is mailing 18,301 refund checks totaling more than $437,000 to people who bought bogus weight-loss products from Colby Fox, Christopher Reinhold and their companies, Tachht, Inc. and Teqqi, LLC. According to the FTC, the defendants bombarded people with illegal spam...
Marketing Architects, Inc. (MAI), an advertising agency that created and disseminated allegedly deceptive radio ads for weight-loss products marketed by its client, Direct Alternatives, has agreed to pay $2 million to the Federal Trade Commission and State of Maine Attorney General’s Office to...
Chemical Free Solutions LLC (CFS), the seller of Cedarcide Original, a line of cedar oil-based products deceptively marketed as effective at stopping and preventing bed bug infestations, has settled Federal Trade Commission charges that it violated a 2013 order barring it from making scientifically...
The Federal Trade Commission and the U.S. Food and Drug Administration (FDA) today posted warning letters to 11 marketers and distributors of opioid cessation products for illegally marketing products with unproven claims about their ability to help in the treatment of opioid addiction and...
CellMark Biopharma, LLC and its CEO have agreed to settle Federal Trade Commission charges that they made false or unsupported claims regarding two health products they marketed as effective treatments for cancer patients’ malnutrition and “chemo fog,” or treatment-related cognitive dysfunction.

Filtering by content type: Public Statement

Filtering by content type: Blog Post

Medical professionals, consumer advocates, industry members, and law enforcers are gathering in Washington right now in anticipation of today’s workshop, The Contact Lens Rule and the Evolving Contact Lens Marketplace. Panelists will scrutinize issues related to competition in the...
The FTC is eyeing its Contact Lens Rule and has announced the agenda for a March 7, 2018, workshop, The Contact Lens Rule and the Evolving Contact Lens Marketplace.
Who among us wouldn’t want to turn back the hands of time? But don’t try to summon the spirit of Ponce de León just yet. According to the FTC, anti-aging claims for TA-65MD and TA-for 65 Skin lacked scientific substantiation. In addition, the FTC challenged the company’s use of...
We haven’t tried bullhorns or signal flares yet, but aside from that, it’s tough to imagine a tactic the FTC hasn’t taken to warn businesses about the risks of involving themselves in deceptive weight loss promotions.
There’s one thing people struggling with opioid addiction need: the facts. And there’s something that can hinder their recovery and perhaps even lead to relapse: unproven treatments promoted with deceptive advertising claims. Partnering with federal health agencies, the FTC has...
So you’ve received a Civil Investigative Demand (CID) from the Federal Trade Commission related to a consumer protection matter. Now what? We appreciate that it can be daunting for any company – especially a small business – and we want to be as transparent as possible about the...
The FTC’s fight against the deceptive marketing of unproven cancer treatments goes back to the early days of the agency, and it’s disappointing that we still need to bring cases of that nature. But you can add the FTC’s settlement with Florida-based CellMark Biopharma and CEO Derek...

Filtering by content type: Closing Letter

Filtering by content type: Case

Pages